1.Intravascular local gene transfer mediated by protein-coated metallic stent
JQ YUAN ; RL GAO ; RW SHI ; LF SONG ; J TANG ; YL LI ; CJ TANG ; L MENG ; WM YUAN ; ZJ CHEN
Chinese Medical Journal 2001;114(10):1043-1045
Objective To assess the feasibility, efficiency and selectivity of adenovirus-mediated gene transfer to local arterial wall by protein-coated metallic stent. Methods A replication-defective recombinant adenovirus carrying the Lac Z reporter gene for nuclear specific β-galactosidase (Ad-βgal) was used in this study. The coating for metallic stent was made by immersing it in a gelatin solution containing crosslinker. The coated stents were mounted on a 4.0 or 3.0 mm percutaneous transluminal coronary angioplasty (PTCA) balloon and submersed into a high-titer Ad-βgal viral stock (2 × 1010 pfu/ml) for 3 min, and then implanted into the carotid artedes in 4 mini-swines and into the left anterior descending branch of the coronary artery in 2 mini-swines via 8F large lumen guiding catheters. The animals were sacrificed 7 (n=4), 14 (n = 1) and 21 (n = 1 ) days after implantation, respectively. The β-galactosidase expression was assessed by X-gal staining. Results The results showed that the expression of transgene was detected in all animal. In 1 of carotid artery with an intact intima, the β-gal expression was limited to endothelial cells. In vessels with denuded endothelium, gene expression was found in the sub-intima, media and adventitia. The transfection efficiency of medial smooth muscle cells was 38.6%. In 2 animals sacrificed 7 days after transfection, a microscopic examination of X-gal-stained samples did not show evidence of transfection in remote organs and arterial segments adjacent to the treated arterial site. Conclusions Adenovirus-mediated arterial gene transfer to endothelial, smooth muscle cells and adventitia by protein-coated metallic stent is feasible. The transfection efficiency is higher. The coated stent may act as a good carrier of adenovirus-mediated gene transfer and have a potential to prevent restenosis following PTCA.
2.Protective mechanism on the vascular pathological process in diabetes mellitus rats by Rheum officeinale.
Feng-Sheng TIAN ; Zhen-Bin LI ; Yuan-Song WANG ; Xiu-Hai SU ; Wen-Dong LI ; Xiao-Yun WANG
China Journal of Chinese Materia Medica 2008;33(6):672-675
OBJECTIVETo explore the protective mechanism of officeihale on the vascular pathological process in diabetes mellitus (DM) rats.
METHODAfter the DM rat model was established, 24 DM rats were randomly divided into model group (12 DM rats) and Rheum officeinale group (12 DM rats). Rheum officeinale was orally given in 10 g kg(-1) per day, and the other two groups were given equal pure water. 8 weeks later, blood samples were collected to determine the level of nitric oxide (NO) and endothelin-1 (ET-1). Thoracic aortic rings was prepared to observe the inhibiting effect of Ach with different concentration on contraction caused by NE. Another part of aorta was made to observe the expression of ICAM-1 and VCAM-1 by method of SP immunohistochemistry staining,
RESULTRheum officeinale group obviously decreased the level of ET-1 and increased the NO compared with model group (P <0.05). The expression of ICAM-1 and VCAM-1 could be obviously inhibited in Rheum officeinale group compared with model group. (P <0.05).
CONCLUSIONRheum officeinale could decrease the level of ET-1 with increased the NO in diabetes rats, and inhibit the expression of ICAM-1 and VCAM-1, which may be mechanisms of protecting the endothelium of vessel in diabetes rats.
Animals ; Aorta ; drug effects ; metabolism ; pathology ; Blood Glucose ; metabolism ; Blood Vessels ; drug effects ; metabolism ; pathology ; Diabetes Mellitus ; pathology ; Drugs, Chinese Herbal ; pharmacology ; Endothelin-1 ; metabolism ; Endothelium, Vascular ; drug effects ; metabolism ; pathology ; Gene Expression Regulation ; drug effects ; Intercellular Adhesion Molecule-1 ; metabolism ; Male ; Nitric Oxide ; metabolism ; Protective Agents ; pharmacology ; Rats ; Rheum ; chemistry